facebook-page-view
Advertisement

Ascent-backed Naari to acquire drug applications portfolio to boost US biz

By Bruhadeeswaran R

  • 08 Jun 2020
Premium
Ascent-backed Naari to acquire drug applications portfolio to boost US biz
Credit: Pixabay

Ascent Capital-backed Naari Pharma Pvt. Ltd is set to acquire a portfolio of abbreviated new drug applications (ANDAs) from a drugmaker that's also backed by private equity investors, according to a person close to the development. Naari, through its wholly owned subsidiary Naari Pte Ltd, is acquiring 10 ANDAs from Intas ......

This is a Premium article. Please subscribe or log in to read the full story!

Here's a selection of our recent premium content.

Already a member? Click here to log in.
Advertisement
Advertisement